Concurrent celecoxib versus placebo in patients with stage II-III non-small cell lung cancer: A randomised phase II trial

被引：12
作者：
De Ruysscher, Dirk
Bussink, Johan
Rodrigus, Patrick
Kessels, Alfons
Dirx, Miranda
Houben, Ruud
Wanders, Rinus
机构：
[1] Univ Hosp Maastricht, Dept Radiat Oncol, GROW, NL-6229 ET Maastricht, Netherlands
[2] MAASTRO Clin, Maastricht, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands
[4] Bernard Verbeeten Inst, Tilburg, Netherlands
[5] Univ Hosp Maastricht, Dept Hlth Technol Assessment, Maastricht, Netherlands
[6] Comprehens Canc Ctr Limburg, Maastricht, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2007年 / 84卷 / 01期
关键词：
COX-2; celecoxib; randomised; phase II; NSCLC; radiotherapy;
D O I：
10.1016/j.radonc.2007.05.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In several pre-clinical models, cyclooxygenase (COX) inhibitors increase radio-sensitivity of tumours, whilst not affecting normal tissues. A randomised phase II trial comparing concurrent radiotherapy with either celecoxib or placebo in patients with stage II-III non-small cell lung cancer was therefore initiated. Because of poor recruitment, the study was stopped after the enrollment of 41 patients, instead of the foreseen 102. None of the endpoints differed significantly between both groups. However, due to the limited number of patients, no definitive conclusions can be drawn. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：23 / 25
页数：3
相关论文
共 50 条
[41]   Definitive radiotherapy alone over 60 Gy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: retrospective analysis [J].
Joo, Ji Hyeon ;
Song, Si Yeol ;
Kim, Su Ssan ;
Jeong, Yuri ;
Jeong, Seong-Yun ;
Choi, Wonsik ;
Choi, Eun Kyung .
RADIATION ONCOLOGY, 2015, 10
[42]   Radiation therapy of stage I and II non-small cell lung cancer (NSCLC) [J].
Zierhut, D ;
Bettscheider, C ;
Schubert, K ;
van Kampen, M ;
Wannenmacher, M .
LUNG CANCER, 2001, 34 :S39-S43
[43]   Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer [J].
Liu, Yue-E ;
Xue, Xiao-Ying ;
Zhang, Rui ;
Chen, Xue-Ji ;
Ding, Yu-Xia ;
Liu, Chao-Xing ;
Qin, Yue-Liang ;
Li, Wei-Qian ;
Ren, Xiao-Cang ;
Lin, Qiang .
BMJ OPEN, 2020, 10 (10)
[44]   Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer [J].
Kalemkerian, GP ;
Belzer, K ;
Wozniak, AJ ;
Gaspar, LE ;
Valdivieso, M ;
Kraut, MJ .
LUNG CANCER, 1999, 25 (03) :175-182
[45]   Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients [J].
Gong, Lei ;
He, Ronghui ;
Xu, Yanjun ;
Luo, Taobo ;
Jin, Kaixiu ;
Yuan, Wuzhou ;
Zheng, Zengguang ;
Liu, Lanxuan ;
Liang, Zebin ;
Li, Ao ;
Zheng, Zhiguo ;
Li, Hui .
THORACIC CANCER, 2021, 12 (15) :2170-2181
[46]   Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter [J].
O. Pradier ;
K. Lederer ;
A. Hille ;
E. Weiss ;
H. Christiansen ;
H. Schmidberger ;
C. F. Hess .
Journal of Cancer Research and Clinical Oncology, 2005, 131 :261-269
[47]   Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial [J].
Masotti, A ;
Zannini, G ;
Gentile, A ;
Morandini, G .
LUNG CANCER, 2002, 36 (01) :99-103
[48]   Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter [J].
Pradier, O ;
Lederer, K ;
Hille, A ;
Weiss, E ;
Christiansen, H ;
Schmidberger, H ;
Hess, CF .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (04) :261-269
[49]   Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group [J].
Koch, Andrea ;
Bergman, Bengt ;
Holmberg, Erik ;
Sederholm, Christer ;
Ek, Lars ;
Kosieradzki, Jaroslaw ;
Lamberg, Kristina ;
Thaning, Lars ;
Ydreborg, Sven-Olof ;
Sorenson, Sverre .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (10) :1546-1555
[50]   Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer [J].
Cheruvu, Praveena ;
Metcalfe, Su K. ;
Metcalfe, Justin ;
Chen, Yuhchyau ;
Okunieff, Paul ;
Milano, Michael T. .
RADIATION ONCOLOGY, 2011, 6
12345